Janssen Pharmaceuticals has agreed to pay the state of Montana $5.9 million in a Risperdal settlement. The state’s attorney general Tim Fox brought the Risperdal lawsuits against the Johnson & Johnson subsidiary, alleging that the company promoted the antipsychotic medication for unapproved and off-label uses. The funds will be divided among hospitals, courts and Risperdal awareness groups.